Episil Holding
Episil Technologies Inc. provides foundry for linear bipolar IC, and foundry with compound GaN and SiC in Taiwan. It also offers High Power MOSFET, Mix-mode integrated circuit, high voltage CMOS, FRD, TVS, SiC, and GaN discrete device manufacturing services. The company was formerly known as Episil Holding Inc. Episil Technologies Inc. was founded in 1985 and is headquartered in Hsinchu City, Tai… Read more
Episil Holding (3707) - Total Liabilities
Latest total liabilities as of September 2025: NT$3.66 Billion TWD
Based on the latest financial reports, Episil Holding (3707) has total liabilities worth NT$3.66 Billion TWD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Episil Holding - Total Liabilities Trend (2009–2024)
This chart illustrates how Episil Holding's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Episil Holding Competitors by Total Liabilities
The table below lists competitors of Episil Holding ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Forge Global Holdings Inc
NYSE:FRGE
|
USA | $45.63 Million |
|
Hongsheng Heat Exchanger Mnfg
SHG:603090
|
China | CN¥280.91 Million |
|
Hangzhou Youngsun Intelligent
SHG:603901
|
China | CN¥5.65 Billion |
|
TSF INVESTMENTS LTD
NSE:TSFINV
|
India | ₹6.44 Billion |
|
PT Unilever Indonesia Tbk
PINK:UNLRF
|
USA | $15.54 Trillion |
|
China Yuchai International Limited
NYSE:CYD
|
USA | $14.75 Billion |
|
Teyi Pharmaceutical Group Co Ltd
SHE:002728
|
China | CN¥417.67 Million |
Liability Composition Analysis (2009–2024)
This chart breaks down Episil Holding's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.08 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.52 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.29 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Episil Holding's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Episil Holding (2009–2024)
The table below shows the annual total liabilities of Episil Holding from 2009 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | NT$4.29 Billion | +1.54% |
| 2023-12-31 | NT$4.22 Billion | -13.09% |
| 2022-12-31 | NT$4.86 Billion | +38.40% |
| 2021-12-31 | NT$3.51 Billion | -7.96% |
| 2020-12-31 | NT$3.82 Billion | -14.90% |
| 2019-12-31 | NT$4.48 Billion | +5.00% |
| 2018-12-31 | NT$4.27 Billion | +45.52% |
| 2017-12-31 | NT$2.93 Billion | +17.31% |
| 2016-12-31 | NT$2.50 Billion | +26.81% |
| 2015-12-31 | NT$1.97 Billion | +43.09% |
| 2014-12-31 | NT$1.38 Billion | +8.61% |
| 2013-12-31 | NT$1.27 Billion | +15.27% |
| 2012-12-31 | NT$1.10 Billion | -22.75% |
| 2011-12-31 | NT$1.43 Billion | -19.98% |
| 2010-12-31 | NT$1.78 Billion | -16.49% |
| 2009-12-31 | NT$2.13 Billion | -- |